Kubota Pharmaceutical Holdings Co., Ltd.

4596・Growth Market・Pharmaceuticals

4596・Growth Market・Pharmaceuticals

Kubota Pharmaceutical Holdings Co., Ltd.4596

Reference Indicators

Market Cap

90¥100M

P/E (Forecast)

—

P/B

4.1x

Dividend Yield (Forecast)

0.00%

ROE

-37.3%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	—	8	39	27	21
Cost of Sales	—	5	11	5	26
Gross Profit	—	2	28	22	-4
SG&A Expenses	—	601	632	710	542
Operating Income	-2,584	-2,038	-1,504	-1,345	-894
Pre-tax Income	-2,616	-2,015	-1,489	-1,332	-676
Net Income	-2,616	-2,015	-1,489	-1,332	-676
EBITDA	-2,525	-1,979	-1,416	-1,279	—
Gross Margin	—	29.5%	70.5%	81.0%	-22.5%
Operating Margin	—	-24691.3%	-3770.7%	-4948.7%	-4194.3%
ROA	-54.1%	-45.6%	-49.4%	-86.4%	-34.2%
ROE	-63.0%	-51.0%	-56.3%	-95.9%	-37.3%

Disclaimer